Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Publication stageIn Press Accepted Manuscript
JEL CodesI11, I18, L51
Precis: “Tiered pricing” systems in which the generic drug price depends on the number of generic entrants are not well understood. We conduct a simulation analysis.
Author Contributions as indicated in Section D of each author’s Authorship Form
Concept and design: Moradpour, Zhang, Anis, Hollis
Acquisition of data: Moradpour, Hollis
Analysis and interpretation of data: Moradpour, Zhang, Grootendorst, Anis, Hollis
Drafting of the manuscript: Moradpour, Grootendorst, Hollis
Critical revision of the paper for important intellectual content: Moradpour, Zhang, Grootendorst, Anis, Hollis
Statistical analysis: Moradpour, Grootendorst
Obtaining funding: Zhang, Anis
Administrative, technical, or logistical support: Moradpour
Conflict of Interest Disclosures
Drs Zhang, Anis, and Hollis reported receiving grants from The Canadian Institutes of Health Research Project Grant (PJT-153280), during the conduct of the study. Dr Hollis reported receiving personal fees from Pharmascience and Apotex, outside the submitted work.
This work was supported by a Canadian Institutes of Health Research Project Grant (PJT-153280)
Role of Funder/Sponsor
The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.